Azitra (AZTR) Free Cash Flow (2022 - 2026)
Azitra (AZTR) reported Free Cash Flow of -$2.5 million for Q1 2026, up 18.87% on a YoY basis from -$2.1 million in Q1 2025, and up 14.28% quarter-over-quarter from -$2.9 million in Q4 2025.
Azitra (AZTR) Free Cash Flow (2022 - 2026) Analysis & Trends
Azitra has reported Free Cash Flow for 5 years, with the latest figure at -$2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 18.87% year-over-year to -$2.5 million; the trailing twelve-month figure through Mar 2026 stood at -$10.7 million (down 3.77% YoY), and the FY2025 full-year result was -$11.2 million, down 9.96% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$2.5 million, up from -$2.9 million in the prior quarter.
- The five-year high for Free Cash Flow was -$1.3 million in Q1 2023, with the low at -$3.1 million in Q1 2025.
- Historically, Free Cash Flow has averaged -$2.4 million across 5 years, with a median of -$2.5 million in 2024.
- Annual changes were most pronounced in 2024 — Free Cash Flow tumbled 129.01% — and 2026, when it increased 18.87%.
- Azitra's Free Cash Flow stood at -$2.2 million in 2022, then dropped by 16.23% to -$2.5 million in 2023, then declined by 3.51% to -$2.6 million in 2024, then decreased by 10.46% to -$2.9 million in 2025, then climbed by 14.28% to -$2.5 million in 2026.
- The last three Free Cash Flow figures came in at -$2.5 million (Q1 2026), -$2.9 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -2.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.49 Mn |
| Mar 31, 2026 | -2.49 Mn |
| Dec 31, 2025 | -2.91 Mn |
| Dec 31, 2025 | -2.91 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.84 Mn |
| Jun 30, 2025 | -2.84 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Dec 31, 2024 | -2.63 Mn |
| Dec 31, 2024 | -2.63 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |